{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:06:27Z","timestamp":1787598387182,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":2968,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1074\/jbc.m112.356584","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T18:26:53Z","timestamp":1340735213000},"page":"28656-28665","source":"Crossref","is-referenced-by-count":47,"title":["The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis"],"prefix":"10.1016","volume":"287","author":[{"given":"Jie","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M112.356584_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.280.5361.243","article-title":"Homeostasis and self-tolerance in the immune system. Turning lymphocytes off","volume":"280","author":"Van Parijs","year":"1998","journal-title":"Science"},{"key":"10.1074\/jbc.M112.356584_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cell.2008.03.026","article-title":"TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis","volume":"133","author":"Sun","year":"2008","journal-title":"Cell"},{"key":"10.1074\/jbc.M112.356584_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0303-8467(02)00035-5","article-title":"Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy","volume":"104","author":"Massacesi","year":"2002","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1074\/jbc.M112.356584_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2005.02.022","article-title":"Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis","volume":"164","author":"Camelo","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1074\/jbc.M112.356584_bib5","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"J\u00e4ger","year":"2009","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2010.01.003","article-title":"Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis","volume":"35","author":"York","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1074\/jbc.M112.356584_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbadis.2010.07.006","article-title":"Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models","volume":"1812","author":"Mars","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M112.356584_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-065X.2006.00437.x","article-title":"TGF-\u03b2. A mobile purveyor of immune privilege","volume":"213","author":"Wahl","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1074\/jbc.M112.356584_bib9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4049\/jimmunol.173.2.828","article-title":"IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice","volume":"173","author":"Anderson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib10","first-page":"222","article-title":"[Suppression of murine EAE by triptolide is related to downregulation of INF-gamma and upregulation of IL-10 secretion in splenic lymphocytes]","volume":"25","author":"Fan","year":"2009","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1074\/jbc.M112.356584_bib11","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/eji.201141666","article-title":"TGF-\u03b2 signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE","volume":"41","author":"Huss","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1044-5323(03)00035-6","article-title":"Fas (CD95\/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology","volume":"15","author":"Brunner","year":"2003","journal-title":"Semin. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1182\/blood-2008-11-189118","article-title":"Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon","volume":"114","author":"Saint Fleur","year":"2009","journal-title":"Blood"},{"key":"10.1074\/jbc.M112.356584_bib14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/ni1489","article-title":"Critical regulation of CD4+ T cell survival and autoimmunity by \u03b2-arrestin 1","volume":"8","author":"Shi","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib15","first-page":"343","article-title":"High-dose sodium valproate therapy for childhood refractory epilepsy","volume":"44","author":"Amano","year":"1990","journal-title":"Jpn J. Psychiatry Neurol."},{"key":"10.1074\/jbc.M112.356584_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00148581-200608020-00004","article-title":"Valproate as a mainstay of therapy for pediatric epilepsy","volume":"8","author":"Guerrini","year":"2006","journal-title":"Paediatr. Drugs"},{"key":"10.1074\/jbc.M112.356584_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary. Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1074\/jbc.M112.356584_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1358\/dot.2009.45.11.1437052","article-title":"Romidepsin for the treatment of cutaneous T-cell lymphoma","volume":"45","author":"Campas-Moya","year":"2009","journal-title":"Drugs Today"},{"key":"10.1074\/jbc.M112.356584_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10637-010-9596-y","article-title":"Histone deacetylase inhibitors. Potential targets responsible for their anti-cancer effect","volume":"28","author":"Dickinson","year":"2010","journal-title":"Invest. New Drugs."},{"key":"10.1074\/jbc.M112.356584_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0707166","article-title":"HDAC inhibitors as anti-inflammatory agents","volume":"150","author":"Adcock","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1074\/jbc.M112.356584_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1620\/tjem.213.329","article-title":"Chronological changes of CD4+ and CD8+ T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis","volume":"213","author":"Sonobe","year":"2007","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1074\/jbc.M112.356584_bib22","first-page":"686","article-title":"Glycolytic inhibitor, 2-deoxy-d-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro","volume":"43","author":"Swamy","year":"2005","journal-title":"Indian J. Exp. Biol."},{"key":"10.1074\/jbc.M112.356584_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/smim.1996.0058","article-title":"The role of the Caspase family of cysteine proteases in apoptosis","volume":"9","author":"Miller","year":"1997","journal-title":"Semin. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.cellbio.15.1.269","article-title":"Biochemical pathways of caspase activation during apoptosis","volume":"15","author":"Budihardjo","year":"1999","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1074\/jbc.M112.356584_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4049\/jimmunol.170.1.341","article-title":"Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death","volume":"170","author":"Nakayama","year":"2003","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib26","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.2174\/092986711795471284","article-title":"Developing histone deacetylase inhibitors as anti-cancer therapeutics","volume":"18","author":"Venugopal","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1074\/jbc.M112.356584_bib27","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1517\/13543784.14.12.1497","article-title":"Histone deacetylase inhibitors. Discovery and development as anticancer agents","volume":"14","author":"Marks","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1074\/jbc.M112.356584_bib28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1074\/jbc.M112.356584_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/CAD.0b013e328012a5db","article-title":"Histone deacetylase inhibitors for epigenetic therapy of cancer","volume":"18","author":"Monneret","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1074\/jbc.M112.356584_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1146\/annurev.immunol.22.012703.104554","article-title":"Control of T cell viability","volume":"22","author":"Marrack","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","article-title":"Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair","volume":"75","author":"Veis","year":"1993","journal-title":"Cell"},{"key":"10.1074\/jbc.M112.356584_bib32","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1128\/MCB.21.15.5063-5070.2001","article-title":"Apoptosis triggered by Myc-induced suppression of Bcl-XL or Bcl-2 is bypassed during lymphomagenesis","volume":"21","author":"Eischen","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1074\/jbc.M112.356584_bib33","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.4049\/jimmunol.162.7.4148","article-title":"Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis","volume":"162","author":"Hotchkiss","year":"1999","journal-title":"J. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.immunol.21.120601.141029","article-title":"Control of apoptosis in the immune system. Bcl-2, BH3-only proteins and more","volume":"21","author":"Marsden","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1074\/jbc.M112.356584_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1189\/jlb.0505238","article-title":"Fas costimulation of naive CD4 T cells is controlled by NF-\u03baB signaling and caspase activity","volume":"79","author":"Maksimow","year":"2006","journal-title":"J. Leukocyte Biol."},{"key":"10.1074\/jbc.M112.356584_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02899671","article-title":"Induction of interdigitating reticulum cell-like differentiation in human monocytic leukemia cells by conditioned medium from IL-2-stimulated helper T-cells","volume":"62","author":"Takahashi","year":"1992","journal-title":"Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol."},{"key":"10.1074\/jbc.M112.356584_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7164\/antibiotics.49.453","article-title":"Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase","volume":"49","author":"Takahashi","year":"1996","journal-title":"J. Antibiot."},{"key":"10.1074\/jbc.M112.356584_bib38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.intimp.2007.05.022","article-title":"Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cells","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1074\/jbc.M112.356584_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/jcbfm.2010.195","article-title":"Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia. The roles of HDAC and MMP-9 inhibition","volume":"31","author":"Wang","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820684010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820684010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M112.356584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T22:19:05Z","timestamp":1687558745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820684010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":39,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0021925820684010"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m112.356584","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}